Search research articles
Contact Us
Filters
Showing results (31-40 of 203) with videos related to
Page
of 21
Sort By:
Clinical and Molecular Hepatology
|
April 23, 2019
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2022
Association of Physical Activity to Sarcopenia, Liver Fibrosis, and Cardiovascular Disease: Need a Closer Look!
Ankur Jindal, Rakesh K Jagdish
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2021
Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
Ashish Kumar Vyas, Ankur Jindal
Alimentary Pharmacology & Therapeutics
|
February 28, 2019
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus
Ashish K Vyas, Ankur Jindal
Hepatology (Baltimore, Md.)
|
June 6, 2021
Letter to the Editor: Response to Terlipressin Plus Albumin in Hepatorenal Syndrome-Need a Closer Look!
Ankur Jindal, Rakesh K Jagdish
The Lancet. Global Health
|
May 18, 2024
TREAT-B or Treat All: time for a broader vision on hepatitis B elimination
Ankur Jindal, Shiv K Sarin
Pharmacology, Biochemistry, and Behavior
|
February 7, 2013
Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Neurochemistry International
|
August 27, 2013
Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Psychopharmacology
|
August 15, 2014
Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 2, 2012
Anxiolytic-like effect of linezolid in experimental mouse models of anxiety
Ankur Jindal, Radhakrishnan Mahesh, Baldev Kumar
Page
of 21
Search research articles
Search
Showing results (31-40 of 203) with videos related to
Sort By:
Page
of 21
Clinical and Molecular Hepatology
|
April 23, 2019
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2022
Association of Physical Activity to Sarcopenia, Liver Fibrosis, and Cardiovascular Disease: Need a Closer Look!
Ankur Jindal, Rakesh K Jagdish
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2021
Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
Ashish Kumar Vyas, Ankur Jindal
Alimentary Pharmacology & Therapeutics
|
February 28, 2019
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus
Ashish K Vyas, Ankur Jindal
Hepatology (Baltimore, Md.)
|
June 6, 2021
Letter to the Editor: Response to Terlipressin Plus Albumin in Hepatorenal Syndrome-Need a Closer Look!
Ankur Jindal, Rakesh K Jagdish
The Lancet. Global Health
|
May 18, 2024
TREAT-B or Treat All: time for a broader vision on hepatitis B elimination
Ankur Jindal, Shiv K Sarin
Pharmacology, Biochemistry, and Behavior
|
February 7, 2013
Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Neurochemistry International
|
August 27, 2013
Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Psychopharmacology
|
August 15, 2014
Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy
Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 2, 2012
Anxiolytic-like effect of linezolid in experimental mouse models of anxiety
Ankur Jindal, Radhakrishnan Mahesh, Baldev Kumar
Page
of 21